Cefazolin and Ganciclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Ganciclovir (ganciclovir). Common drug interactions include infected skin ulcer among females and cytomegalovirus infection among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Ganciclovir. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Ganciclovir?

Ganciclovir has active ingredients of ganciclovir. eHealthMe is studying from 6,370 Ganciclovir users. Check the latest studies of Ganciclovir.



On Jul, 16, 2026

91 people who take Cefazolin and Ganciclovir together, and have interactions are studied.

Cefazolin and Ganciclovir drug interactions.

What are the common drug interactions of Cefazolin and Ganciclovir, by gender? *:

female:

  1. Infected skin ulcer
  2. White blood cell count decreased
  3. Bacterial infection
  4. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Multi-organ failure (multisystem organ failure)
  7. Cerebral haemorrhage (bleeding within the brain)
  8. Chills (felling of cold)
  9. Blood immunoglobulin g decreased
  10. Blood pressure decreased

male:

  1. Cytomegalovirus infection
  2. Fungaemia (fungi circulate in the blood)
  3. Scedosporium infection (a filamentous fungus which occasionally causes infections in humans)
  4. Septic shock (shock due to blood infection)
  5. Cardiac arrest
  6. Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
  7. Depressed level of consciousness
  8. Drug ineffective
  9. Pneumonia
  10. Pulmonary oedema (fluid accumulation in the lungs)

What are the common drug interactions of Cefazolin and Ganciclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Asteatosis (any disease that persistently causes the skin to dry)
  2. Bacterial infection
  3. Diarrhoea
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Hypertension (high blood pressure)
  6. Oral herpes (viral infection of mouth)
  7. Upper respiratory tract inflammation
  8. Disease recurrence
  9. Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli)
  10. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)

10-19:

  1. Fatigue (feeling of tiredness)
  2. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  3. Hypertension (high blood pressure)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Pyelonephritis (inflammation of kidney caused by bacteria)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Blood immunoglobulin g decreased
  8. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
  9. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)
  10. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)

20-29:

  1. Altered state of consciousness (altered state of mind)
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  3. Fungaemia (fungi circulate in the blood)
  4. Hemiparesis (weakness on one side of the body)
  5. Influenza
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Pneumonia bacterial (pneumonia associated with bacterial infection)
  8. Scedosporium infection (a filamentous fungus which occasionally causes infections in humans)
  9. Septic shock (shock due to blood infection)
  10. Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)

30-39:

  1. Abdominal distension
  2. Cytomegalovirus gastrointestinal infection (virus infection of stomach and intestine)
  3. Bacterial infection
  4. Complications of transplanted kidney
  5. Cough
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  8. Multi-organ failure (multisystem organ failure)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Nephropathy toxic (damage to kidney due to toxins)

40-49:

  1. Calciphylaxis (is a syndrome with vascular calcium accumulation)
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Cytomegalovirus infection
  4. Infected skin ulcer
  5. Urinary tract infection
  6. White blood cell count decreased
  7. Depression
  8. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  9. Hyperhomocysteinaemia (abnormally high level of homocysteine in the blood)
  10. Injury

50-59:

  1. Urinary tract obstruction
  2. Urinoma (a collection of extravasated urine)
  3. Cytomegalovirus test positive
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Angina pectoris (chest pain due to ischemia of the heart muscle)
  6. Bacterial infection
  7. Cardiac arrest
  8. Collapse (sudden functional breakdown)
  9. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  10. Drug toxicity

60+:

  1. Diarrhoea
  2. Pyrexia (fever)
  3. Chills (felling of cold)
  4. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  5. Asthma
  6. Bacteraemia (presence of bacteria in the blood)
  7. Bacterial infection
  8. Blood pressure decreased
  9. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  10. Coma (state of unconsciousness lasting more than six hours)

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 15 people, 16.48%
  2. Pneumonia: 10 people, 10.99%
  3. Fungal Infection: 7 people, 7.69%
  4. Fainting (loss of consciousness and postural tone): 7 people, 7.69%
  5. Cytomegalovirus Infection: 7 people, 7.69%
  6. Multiple Myeloma (cancer of the plasma cells): 6 people, 6.59%
  7. Lymphoma (cancer that begins in immune system cells): 5 people, 5.49%
  8. Insomnia (sleeplessness): 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and Ganciclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin and Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ganciclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and ganciclovir (the active ingredients of Cefazolin and Ganciclovir, respectively), and Cefazolin and Ganciclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: